Compare UUUU & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UUUU | BLLN |
|---|---|---|
| Founded | 1987 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.3B |
| IPO Year | 2006 | N/A |
| Metric | UUUU | BLLN |
|---|---|---|
| Price | $19.91 | $63.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $19.92 | ★ $129.57 |
| AVG Volume (30 Days) | ★ 9.0M | 305.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,922,000.00 | N/A |
| Revenue This Year | $113.24 | $35.42 |
| Revenue Next Year | $36.77 | $32.30 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.20 | $64.74 |
| 52 Week High | $27.90 | $138.70 |
| Indicator | UUUU | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 32.86 |
| Support Level | $19.34 | N/A |
| Resistance Level | $23.61 | $100.28 |
| Average True Range (ATR) | 1.70 | 7.38 |
| MACD | -0.28 | -1.10 |
| Stochastic Oscillator | 24.34 | 5.70 |
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.